CureVac Investor Relations Material
Latest events
Q4 2023
CureVac
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from CureVac N.V.
Access all reports
Segment Data
Access more data
Revenue by
Geography
Belgium
Switzerland
Netherlands
Expenses by
Financials
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). Its product candidates are also developed for prophylactic vaccines, cancer immunotherapy and other therapeutic areas. The company's lead product candidate is CVnCoV that is in Phase I human clinical trials to protect against coronaviruses, including the SARS-CoV-2 virus. It also develops additional prophylactic vaccine antibiotics, including CV301, which is in Phase II clinical trials for treating non-small cell lung cancer and cervical cancer; CV9202 in preclinical stage for treating melanoma and prostate cancer; and CV8102 preclinical stage for treating breast and pancreatic cancers.
The company's mRNA therapeutics have demonstrated their potential to treat cancers through the triggering of intracellular immune responses. CureVac N.V. operates in the United States, Germany, and internationally. The company was formerly known as Curevac GmbH and changed its name to CureVac N.V. in December 2016.
Key slides for CureVac N.V.
Q3 2023
CureVac N.V.
Q3 2023
CureVac N.V.
Latest articles
Adidas vs Puma: The Story of the Dassler Brothers
An in-depth article outlining the story of the Dassler brothers, their feud with one another, and the history of Puma and Adidas.
10 May 2024
Satya Nadella: The Architect of Microsoft's Resurgence
The journey of Satya Nadella, from his early life in India to reshaping Microsoft as its CEO, emphasizing cloud computing and inclusive leadership.
10 May 2024
The Suppliers Making the iPhone Possible
An article exploring the relationship of the suppliers working with Apple to make the iPhone and other products possible.
8 May 2024
Ticker symbol
Country
🇺🇸 United States